Does RELUGOLIX Cause Product distribution issue? 243 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 243 reports of Product distribution issue have been filed in association with RELUGOLIX (Orgovyx). This represents 1.2% of all adverse event reports for RELUGOLIX.
243
Reports of Product distribution issue with RELUGOLIX
1.2%
of all RELUGOLIX reports
0
Deaths
7
Hospitalizations
How Dangerous Is Product distribution issue From RELUGOLIX?
Of the 243 reports, 7 (2.9%) required hospitalization.
Is Product distribution issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RELUGOLIX. However, 243 reports have been filed with the FAERS database.
What Other Side Effects Does RELUGOLIX Cause?
Hot flush (6,845)
Fatigue (5,203)
Therapy interrupted (3,251)
Incorrect dose administered (1,917)
Asthenia (1,718)
Arthralgia (1,385)
Diarrhoea (1,383)
Product dose omission issue (1,189)
Dizziness (1,146)
Constipation (902)
What Other Drugs Cause Product distribution issue?
LENALIDOMIDE (858)
CERTOLIZUMAB PEGOL (403)
SECUKINUMAB (340)
RUXOLITINIB (301)
HUMAN IMMUNOGLOBULIN G (279)
POMALIDOMIDE (254)
VEDOLIZUMAB (150)
PIMAVANSERIN (134)
TEDUGLUTIDE (132)
HUMAN C1-ESTERASE INHIBITOR (107)
Which RELUGOLIX Alternatives Have Lower Product distribution issue Risk?
RELUGOLIX vs REMDESIVIR
RELUGOLIX vs REMERON
RELUGOLIX vs REMICADE
RELUGOLIX vs REMIFENTANIL
RELUGOLIX vs REMIMAZOLAM